Videos
Essential Medicines List, Orphan Drugs, and Paid Plasma
In the Tuesday morning WFH session on global surveillance and collaboration, Brian O’Mahony, provides his vision for the role of
Year: 2025
Language: English
This resource is also available in:
This video gives a quick introduction to ultra-long half-life (UHL) clotting factor replacement therapy.
Learn more about different treatment options for hemophilia with the World Federation of Hemophilia Shared Decision Making tool!
The WFH does not engage in the practice of medicine and under no circumstances recommends particular treatment for specific individuals. For diagnosis or consultation on a specific medical problem, the WFH recommends that you contact your physician or local treatment centre. Before administering any products, the WFH urges patients to check dosages with a physician or hemophilia centre staff, and to consult the pharmaceutical company’s printed instructions.
The WFH does not promote any particular pharmaceutical product and any mention of any commercial brand in this presentation is strictly for educational purposes.
In the Tuesday morning WFH session on global surveillance and collaboration, Brian O’Mahony, provides his vision for the role of
In the Tuesday morning WFH session on global surveillance and collaboration, David Page, discusses donor deferrals, issues of blood safety
In the Tuesday morning medical plenary, Erik Berntorp describes his vision of hemophilia treatment and medical advances in 2030.
On December 16, 2016, the WFH in collaboration with the ISTH, recorded a live interactive webinar on the challenges and
In the Vice President Medical’s plenary of the WFH 2016 World Congress, Marijke van den Berg, discusses how bleeds may
